Lincotus PD Expectorant is a combination syrup formulated to provide effective relief from respiratory conditions characterized by productive cough and bronchial congestion. It contains Ambroxol 15mg/5ml, Levosalbutamol 0.5mg/5ml, and Guaifenesin 50mg/5ml, each contributing to its multifaceted therapeutic action. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, thereby improving airway patency. Levosalbutamol, a selective β2-adrenergic agonist, provides bronchodilation by relaxing bronchial smooth muscles, which helps alleviate bronchospasm and enhances airflow. Guaifenesin serves as an expectorant, promoting the hydration of respiratory tract secretions and making mucus less tenacious, which aids in its expulsion through coughing. The synergistic effect of these active ingredients makes Lincotus PD Expectorant suitable for managing conditions such as acute and chronic bronchitis, asthma exacerbations with mucus hypersecretion, and other obstructive airway diseases. It is intended for use under medical supervision, with dosage adjusted according to patient age and clinical condition. Caution is advised in patients with hypersensitivity to any component, cardiovascular disorders, or hyperthyroidism. This formulation supports symptomatic relief, improves respiratory function, and enhances patient comfort during respiratory illness.